## Abstract The growth characteristics and the antigenic profile of two human melanoma established cell lines __in vitro__ are reported. The growth curves of the two cell lines show some peculiar features which are also detected in their DNA distribution content. In the late stages of growth, in fa
Detection of tumor-associated antigen in human melanoma cell line supernatants
β Scribed by Elizabeth A. Grimm; Hulbert K. B. Silver; Jack A. Roth; Darwin O. Chee; Rishab K. Gupta; Donald L. Morton
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- French
- Weight
- 477 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Spent tissue culture medium (CDMβS) removed from a single cell line of human malignant melanoma grown in serumβfree CDM, contained tumorβassociated antigenic activity. Antibodies to CDMβS measured by complement fixation were detected in 44% (31/70) melanoma, 55% (15/27) sarcoma, 63% (24/38) carcinoma and 15% (11/72) normal sera. Delayed cutaneous hypersensitivity reactions (DCHR) were demonstrated in 4/5 melanoma patients at a 500 ΞΌg dose, 3/5 at a 100 ΞΌg dose and in 1/7 carcinoma patients at the 500 ΞΌg dose. One ml of CDMβS was shown to contain antigen equivalent to that obtained from the membranes of 2.9 Γ 10^7^ tissueβcultured melanoma cells. After purification, 84% (16/19) sera from melanoma patients, 66% (12/18) from sarcoma and carcinoma patients and 8% (2/26) from normal controls were positive to the antigen by complement fixation.
π SIMILAR VOLUMES
a n melanoma-associated antigen was solubilized from fresh surgical specimens by 3 M KCl extraction. T h e antigenicity of this extract was demonstrated by delayed cutaneous hypersensitivity responses and inhibition of complement fixation. Twenty-one of 33 melanoma patients had delayed cutaneous hyp
We have isolated and characterized a melanoma tumor-associated antigen (TAA) from the spent culture medium of a melanoma cell line. Its presence has been detected in 72% of different melanoma specimens but not in normal tissues. Because tumor antigens may stimulate or perhaps block immune reactions
The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of huma
## Abstract All human T lymphoblast cell lines have been derived from subjects with leukemia secondary to thymic lymphoblastic lymphoma, a T cell malignacy, suggesting that such lines represent established cultures of neoplastic T cells. Based on this observation, we prepared rabbit antisera to T c
Peptide epitopes derived from differentiation antigens of the melanocyte lineage have been identified in human melanomas and normal cultured melanocytes as targets for MHC-restricted